Complete Filing Data
Melar Acquisition Corp. I/Cayman reported Stockholders Equity of -$6.99 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Melar Acquisition Corp. I/Cayman did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income * | $5.5M |
| Operating Income Loss | -$1.5M |
| General And Administrative Expense | $1.5M |
| Nonoperating Income Expense | $7.0M |
| Payment Of General And Administrative Costs Through Promissory Note | |
| Interest Expense Debt | $539.9K |
| Interest Income Nonoperating |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | $1.1M | $1.6M | $1.6M | $2.4M | $106.3K | -$19.1K |
| Operating Income Loss | -$712.0K | -$233.3K | -$156.9K | -$130.4K | -$88.6K | -$19.1K |
| General And Administrative Expense | $712.0K | $233.3K | $156.9K | $130.4K | $88.6K | $19.1K |
| Nonoperating Income Expense | $1.8M | $1.8M | $1.7M | $2.5M | $194.9K | |
| Payment Of General And Administrative Costs Through Promissory Note | $10.4K | |||||
| Interest Expense Debt | $383.8K | $109.00 | ||||
| Interest Income Nonoperating | $392.4K | $2.5K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$7.0M | -$5.5M |
| Assets Held In Trust Noncurrent | $171.4M | $164.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $32.1K | $878.3K |
| Interest Income Cash Held In Operating Account | $531.00 | |
| Retained Earnings Accumulated Deficit | -$7.0M | -$5.5M |
| Liabilities Current | $4.3M | $41.3K |
| Liabilities And Stockholders Equity | $175.3M | $165.5M |
| Liabilities | $10.9M | $6.6M |
| Assets Current | $3.9M | $1.0M |
| Assets | $175.3M | $165.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$846.2K | |
| Underwriting Fee Payable Noncurrent | ||
| Accretion Of Temporary Equity To Redemption Value Adjustments | ||
| Accounts Payable Current | ||
| Change In Fair Value Of Over Allotment Option Liability | ||
| Overallotment Liability At Initial Public Offering Date | ||
| Deferred Underwriting Fee Payable | ||
| Repayments Of Debt | ||
| Accretion To Redemption Value Of Temporary Equity | ||
| Other Liabilities Current | $3.7M | |
| Temporary Equity Accretion To Redemption Value | $7.0M | |
| Notes And Loans Receivable Net Current | $3.8M | |
| Temporary Equity Accretion To Redemption Value Adjustment | ||
| Deferred Underwriting Fee Noncurrent | $6.6M | $6.6M |
| Accounts Payable And Accrued Liabilities Current | $577.0K | $41.3K |
| Over Allotment Option Liability | ||
| Changein Fair Valueof Over Allotment Option Liability |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$6.6M | -$5.9M | -$5.7M | -$5.4M | -$5.4M | $5.9K | |
| Assets Held In Trust Noncurrent | $169.7M | $167.9M | $166.1M | $162.5M | $160.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $286.3K | $555.8K | $693.1K | $934.1K | $1.0M | ||
| Interest Income Cash Held In Operating Account | $109.00 | $169.00 | $207.00 | $743.00 | |||
| Retained Earnings Accumulated Deficit | -$6.6M | -$5.9M | -$5.7M | -$5.4M | -$5.4M | ||
| Liabilities Current | $4.1M | $291.8K | $32.8K | $11.3K | $160.3K | ||
| Liabilities And Stockholders Equity | $173.8M | $168.9M | $167.1M | $163.7M | $161.5M | ||
| Liabilities | $10.7M | $6.9M | $6.6M | $6.6M | $6.8M | ||
| Assets Current | $4.0M | $977.7K | $916.3K | $1.1M | $1.2M | ||
| Assets | $173.8M | $168.9M | $167.1M | $163.7M | $161.5M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$185.1K | $1.0M | |||||
| Underwriting Fee Payable Noncurrent | $6.6M | $6.6M | $6.6M | $6.6M | $6.6M | $6.6M | |
| Accretion Of Temporary Equity To Redemption Value Adjustments | $1.8M | $1.8M | $1.7M | $2.4M | $12.4M | ||
| Accounts Payable Current | $500.0K | $63.6K | $32.8K | $41.3K | $11.3K | $16.1K | |
| Change In Fair Value Of Over Allotment Option Liability | $141.8K | $27.4K | |||||
| Overallotment Liability At Initial Public Offering Date | $169.1K | ||||||
| Deferred Underwriting Fee Payable | $6.6M | ||||||
| Repayments Of Debt | $249.4K | ||||||
| Accretion To Redemption Value Of Temporary Equity | $12.4M | ||||||
| Other Liabilities Current | $3.6M | $228.2K | $2.4K | ||||
| Temporary Equity Accretion To Redemption Value | |||||||
| Notes And Loans Receivable Net Current | $3.6M | $230.6K | |||||
| Temporary Equity Accretion To Redemption Value Adjustment | $2.4M | $12.4M | |||||
| Deferred Underwriting Fee Noncurrent | |||||||
| Accounts Payable And Accrued Liabilities Current | |||||||
| Over Allotment Option Liability | $141.8K | ||||||
| Changein Fair Valueof Over Allotment Option Liability | $141.8K | $27.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Cash Provided By Used In Operating Activities | -$774.3K |
| Increase Decrease In Prepaid Expense | -$165.5K |
| Net Cash Provided By Used In Investing Activities | -$3.3M |
| Net Cash Provided By Used In Financing Activities | $3.2M |
| Increase Decrease In Accounts Payable | |
| Proceeds From Issuance Of Warrants | |
| Payments Of Stock Issuance Costs | |
| Payments For Investment Of Cash In Trust Account | |
| Proceeds From Sale Of Units Net Of Underwriting Discounts Paid | |
| Increase Decrease In Due To Related Parties | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $535.7K |
| Proceeds From Other Debt | $3.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q2 2024 | Q1 2024 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$185.1K | -$386.4K | |
| Increase Decrease In Prepaid Expense | $20.0K | $313.8K | |
| Net Cash Provided By Used In Investing Activities | -$160.0M | ||
| Net Cash Provided By Used In Financing Activities | $161.4M | ||
| Increase Decrease In Accounts Payable | -$8.4K | $16.1K | $13.1K |
| Proceeds From Issuance Of Warrants | $5.0M | ||
| Payments Of Stock Issuance Costs | $327.1K | ||
| Payments For Investment Of Cash In Trust Account | $160.0M | ||
| Proceeds From Sale Of Units Net Of Underwriting Discounts Paid | $157.0M | ||
| Increase Decrease In Due To Related Parties | $2.4K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | |||
| Proceeds From Other Debt |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | ||
| Preferred Stock Shares Issued | ||
| Temporary Equity Shares Outstanding |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Temporary Equity Shares Outstanding | 16.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Investment Income Interest | ||
| Prepaid Expense Excluding Insurance Current | ||
| Stock Issued During Period Value New Issues | ||
| Prepaid Insurance Noncurrent | ||
| Stock Issued1 | ||
| Notes Issued1 | ||
| Formation Costs Paid By Sponsor In Exchange For Shares | ||
| Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs | ||
| Prepaid Expense Current | $70.9K | $165.5K |
| Offering Costs Charged To Additional Paid In Capital | ||
| Investment Income Interest And Dividend | $7.0M | |
| Prepaid Insurance | ||
| Prepaid Expense Other Noncurrent | $70.9K | |
| Paymentof Invoiceson Behalfof Everli | $3.3M | |
| Interest Due From Everli | $555.9K | |
| Formation Costs Paid By Sponsor |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Investment Income Interest | $1.8M | $1.8M | $1.7M | $2.4M | $167.5K | ||
| Prepaid Expense Excluding Insurance Current | $131.0K | $191.3K | $223.2K | $165.5K | $170.6K | $23.7K | |
| Stock Issued During Period Value New Issues | $25.0K | ||||||
| Prepaid Insurance Noncurrent | $33.1K | $70.9K | $109.4K | $142.6K | |||
| Stock Issued1 | $18.8K | $18.9K | |||||
| Notes Issued1 | $239.0K | $37.5K | |||||
| Formation Costs Paid By Sponsor In Exchange For Shares | 6.2K | ||||||
| Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs | -$160.6K | ||||||
| Prepaid Expense Current | |||||||
| Offering Costs Charged To Additional Paid In Capital | $584.9K | ||||||
| Investment Income Interest And Dividend | |||||||
| Prepaid Insurance | $147.5K | ||||||
| Prepaid Expense Other Noncurrent | |||||||
| Paymentof Invoiceson Behalfof Everli | |||||||
| Interest Due From Everli | |||||||
| Formation Costs Paid By Sponsor | $6.1K |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.